Positive News SentimentPositive NewsNYSE:OMI Owens & Minor (OMI) Stock Price, News & Analysis $15.49 -0.23 (-1.46%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$15.45▼$15.8550-Day Range$12.59▼$16.4852-Week Range$12.36▼$28.35Volume390,421 shsAverage Volume791,550 shsMarket Capitalization$1.18 billionP/E RatioN/ADividend YieldN/APrice Target$20.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Owens & Minor alerts: Email Address Owens & Minor MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside29.1% Upside$20.00 Price TargetShort InterestBearish7.84% of Float Sold ShortDividend StrengthN/ASustainability-1.52Upright™ Environmental ScoreNews SentimentN/AInsider TradingN/AProj. Earnings Growth21.66%From $1.57 to $1.91 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.71 out of 5 starsMedical Sector52nd out of 910 stocksMedical & Hospital Equipment Industry2nd out of 3 stocks 4.0 Analyst's Opinion Consensus RatingOwens & Minor has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 4 hold ratings, and 2 sell ratings.Amount of Analyst CoverageOwens & Minor has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Owens & Minor's stock forecast and price target. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.84% of the float of Owens & Minor has been sold short.Short Interest Ratio / Days to CoverOwens & Minor has a short interest ratio ("days to cover") of 5.6.Change versus previous monthShort interest in Owens & Minor has recently increased by 38.86%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldOwens & Minor does not currently pay a dividend.Dividend GrowthOwens & Minor does not have a long track record of dividend growth. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreOwens & Minor has received a 54.05% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Delivery of medicine and medical equipment", "Medical laboratory equipment", and "Diagnostic and treatment equipment" products. See details.Environmental SustainabilityThe Environmental Impact score for Owens & Minor is -1.52. Previous Next 2.7 News and Social Media Coverage News SentimentOwens & Minor has a news sentiment score of 1.83. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.Search InterestOnly 3 people have searched for OMI on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Owens & Minor insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.59% of the stock of Owens & Minor is held by insiders.Percentage Held by Institutions98.04% of the stock of Owens & Minor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Owens & Minor's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Owens & Minor are expected to grow by 21.66% in the coming year, from $1.57 to $1.91 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Owens & Minor is -30.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Owens & Minor is -30.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioOwens & Minor has a PEG Ratio of 0.50. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioOwens & Minor has a P/B Ratio of 1.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Owens & Minor's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Golden CrestBiden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << About Owens & Minor Stock (NYSE:OMI)Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Richmond, Virginia.Read More OMI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OMI Stock News HeadlinesAugust 28, 2024 | americanbankingnews.comOwens & Minor (NYSE:OMI) Rating Lowered to Hold at StockNews.comAugust 7, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Merus (MRUS), Twist Bioscience (TWST) and Owens & Minor (OMI)September 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 7, 2024 | ca.finance.yahoo.comOMI Aug 2024 23.000 callAugust 6, 2024 | finance.yahoo.comAnalyst Estimates: Here's What Brokers Think Of Owens & Minor, Inc. (NYSE:OMI) After Its Second-Quarter ReportAugust 5, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Owens & Minor (OMI), Tandem Diabetes Care (TNDM) and Alignment Healthcare (ALHC)August 5, 2024 | finance.yahoo.comOwens & Minor Second Quarter 2024 Earnings: EPS Misses ExpectationsAugust 4, 2024 | seekingalpha.comOwens & Minor, Inc. (OMI) Q2 2024 Earnings Call TranscriptSeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.August 3, 2024 | globenewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owens & Minor, Inc. - OMIAugust 3, 2024 | msn.comOwens & Minor, Inc. (NYSE:OMI) Q2 2024 Earnings Call TranscriptAugust 3, 2024 | uk.finance.yahoo.comQ2 2024 Owens & Minor Inc Earnings CallAugust 2, 2024 | prnewswire.comOMI Investors Have Opportunity to Join Owens & Minor, Inc. Fraud Investigation with the Schall Law FirmAugust 2, 2024 | markets.businessinsider.comOwens & Minor Q2 Earnings SummaryAugust 2, 2024 | finance.yahoo.comOwens & Minor Reports Second Quarter 2024 Financial ResultsAugust 2, 2024 | msn.comOwens & Minor beats top-line and bottom-line estimates; reaffirms FY24 outlookAugust 2, 2024 | finance.yahoo.comHealthcare Logistics Provider Owens & Minor Calls Q2 Performance Consistent With Expectations, Reiterates Annual GuidanceAugust 1, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Owens & Minor, Inc. - OMISee More Headlines Receive OMI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Owens & Minor and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/02/2024Today9/07/2024Next Earnings (Estimated)11/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Medical & hospital equipment Sub-IndustryHealth Care Distributors Current SymbolNYSE:OMI CUSIP69073210 CIK75252 Webwww.owens-minor.com Phone(804) 723-7000Fax804-723-7100Employees13,700Year Founded1882Price Target and Rating Average Stock Price Target$20.00 High Stock Price Target$26.00 Low Stock Price Target$16.00 Potential Upside/Downside+29.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage8 Analysts Profitability EPS (Most Recent Fiscal Year)($0.51) Trailing P/E RatioN/A Forward P/E Ratio9.87 P/E Growth0.5Net Income$-41,300,000.00 Net Margins-0.40% Pretax Margin-0.32% Return on Equity14.66% Return on Assets2.52% Debt Debt-to-Equity Ratio2.17 Current Ratio1.09 Quick Ratio0.51 Sales & Book Value Annual Sales$10.53 billion Price / Sales0.11 Cash Flow$5.11 per share Price / Cash Flow3.03 Book Value$11.16 per share Price / Book1.39Miscellaneous Outstanding Shares76,499,000Free Float73,753,000Market Cap$1.18 billion OptionableOptionable Beta0.39 Social Links The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Edward A. Pesicka (Age 56)President, CEO & Director Comp: $2.56MMr. Alexander J. Bruni (Age 48)Executive VP & CFO Comp: $966.35kMr. Andrew G. Long (Age 59)Executive VP and CEO of Products & Healthcare Services Segment Comp: $1.28MMr. Daniel J. Starck (Age 57)Executive Vice President of Business Excellence Comp: $1.43MMr. Perry A. Bernocchi (Age 65)Executive VP & CEO of Patient Direct Segment Comp: $1.25MMr. Michael Wayne Lowry (Age 62)Senior VP, Corporate Controller & Chief Accounting Officer Comp: $261.66kMr. Heath H. Galloway (Age 47)Executive VP, General Counsel & Corporate Secretary Mr. Jonathan A. Leon (Age 57)Senior VP & Corporate Treasurer Trudi AllcottDirector of Media RelationsMore ExecutivesKey CompetitorsPatterson CompaniesNASDAQ:PDCOMcKessonNYSE:MCKCencoraNYSE:CORCardinal HealthNYSE:CAHHenry ScheinNASDAQ:HSICView All CompetitorsInsiders & InstitutionsDana Investment Advisors Inc.Bought 160,682 shares on 8/27/2024Ownership: 0.796%LHM Inc.Bought 48,055 shares on 8/22/2024Ownership: 0.187%Algert Global LLCBought 39,947 shares on 8/16/2024Ownership: 0.125%Quarry LPBought 1,561 shares on 8/16/2024Ownership: 0.003%The Manufacturers Life Insurance Company Bought 1,709 shares on 8/15/2024Ownership: 0.048%View All Insider TransactionsView All Institutional Transactions OMI Stock Analysis - Frequently Asked Questions How have OMI shares performed this year? Owens & Minor's stock was trading at $19.27 at the beginning of the year. Since then, OMI shares have decreased by 19.6% and is now trading at $15.49. View the best growth stocks for 2024 here. How were Owens & Minor's earnings last quarter? Owens & Minor, Inc. (NYSE:OMI) issued its earnings results on Friday, August, 2nd. The company reported $0.36 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.03. The firm's revenue was up 4.2% compared to the same quarter last year. What is Ed Pesicka's approval rating as Owens & Minor's CEO? 36 employees have rated Owens & Minor Chief Executive Officer Ed Pesicka on Glassdoor.com. Ed Pesicka has an approval rating of 65% among the company's employees. Does Owens & Minor have any subsidiaries? The following companies are subsidiaries of Owens & Minor: Halyard Health - S&IP, Byram Healthcare Centers, ArcRoyal, Medical Action Industries, Movianto, The Burrows Company, McKesson's Acute-Care Medical, and others. Who are Owens & Minor's major shareholders? Top institutional shareholders of Owens & Minor include Deerfield Management Company L.P. Series C (8.33%), Dimensional Fund Advisors LP (5.93%), Renaissance Technologies LLC (1.63%) and Bank of New York Mellon Corp (0.85%). Insiders that own company stock include Edward A Pesicka, Jeffrey T Jochims, Perry A Bernocchi, Jonathan A Leon, Michael Wayne Lowry, Snehashish Sarkar, Heath H Galloway, Alexander J Bruni, Robert J Henkel, Gwendolyn M Bingham, Mark A Beck, Louis Emmanuel Castro, Andrew G Long and Nicholas J Pace. View institutional ownership trends. How do I buy shares of Owens & Minor? Shares of OMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Owens & Minor own? Based on aggregate information from My MarketBeat watchlists, some other companies that Owens & Minor investors own include Advanced Micro Devices (AMD), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Micron Technology (MU), NVIDIA (NVDA) and Applied Materials (AMAT). This page (NYSE:OMI) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Owens & Minor, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Owens & Minor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.